Four Canada Finalists Named in IsaBody Challenge to Compete for CA$10,000
Health and Wellness Competition Inspires Total-Mind and Body Transformations
GILBERT, Ariz. (June 12, 2019) — Isagenix International, a global health and wellness company providing nutrition and lifestyle solutions, has announced the first four Canada finalists of its annual total-body transformation program, the IsaBody Challenge®. The first Judging Period’s finalists are Cristin Richardson of Guelph, Ontario; Laurie Barkman of Winnipeg, Manitoba; Murray Marchak of Victoria, British Columbia; and Paul Starling of Lindsay, Ontario.
These four individuals were selected out of the thousands of people across Canada who completed the IsaBody Challenge during the most recent judging period. Each finalist has won CA$3,000 and the chance to compete for the grand prize of CA$10,000. Finalists will also receive a CA$200 product coupon, a photo shoot, an all-expenses-paid trip to the IsaBody™ Escape for themselves and a guest, and other prizes to recognize their achievements.
Each finalist will be introduced onstage at the Isagenix Canada Celebration 2020 in February in Montreal, Quebec, in front of thousands of attendees. The grand prize winner will be announced at the event. The IsaBody Challenge and Canada Celebration are both hosted by Isagenix.
“Our Canada finalists have demonstrated a resilience and strength of character that is truly exemplary,” said Travis Ogden, chief executive officer of Isagenix. “We’re proud to honor their commitment to transforming their lives and the example they set for others as they pair discipline with our exceptional nutrition solutions. We congratulate them knowing they’ll continue to inspire as they continue on this path to enhanced wellness.”
Meet the Finalists
Cristin Richardson, Ontario
Age: 39
Total Challenges Completed: 3
Total Weight Loss Over Completed Challenges: 19 pounds*
One year ago, Cristin was exhausted, sick, and just trying to survive physically and emotionally as a mother to her young son. She credits Isagenix in helping her regain her energy and mental balance to cope with the challenges motherhood has thrown her way and with becoming an athlete again. Now she’s able to hike and go on adventures with her son, and she’s smashing new physical goals as a recent Black Belt Grand Champion in her dojo, competing and winning against people half her age.
Laurie Barkman, Manitoba
Age: 53
Total Challenges Completed: 3
Total Weight Loss Over Completed Challenges: 38 pounds*
Tired, overweight, and unenergetic, Laurie still had the strength to say, “Enough!” and make drastic changes that allowed her to finally like what she sees in the mirror. Nearly 40 pounds down,* she’s regained confidence and determination and replaced fat with lean muscle to become stronger and healthier. Her newfound confidence affects all areas of her life, pushing her to speak up, reach out, try new things, and inspire others. She’s even competed in her first-ever bikini competition at age 53, placing fourth and meeting her goal of finishing in the top five.
Murray Marchak, British Columbia
Age: 48
Total Challenges Completed: 9
Total Weight Loss During Completed Challenges: 30 pounds* Murray always considered himself an average guy with a body he wasn’t proud of but wasn’t really worried about until a doctor’s visit where he was told to lose weight and lower his cholesterol, or he’d be put on daily medication. This lit a fire in Murray to make dramatic changes in his lifestyle that included losing more than 70 pounds (30 total during IsaBody Challenges). More importantly, he now uses an online forum to inspire more than 600 other average guys just like him who are trying to improve their overall health and wellness to accomplish their goals.
Paul Starling, Ontario
Age: 52
Total Challenges Completed: 7
Total Weight Loss Over Completed Challenges: 50 pounds*Prior to Isagenix, Paul wasn’t able to stick with a diet for more than two weeks. Now, he’s down 50 pounds* and loving the simplicity of the wellness program that allows him to maintain his newfound physique. Paul is focused on gaining lean muscle and toning as he increases energy and strength with early-morning visits to the gym. While he once dreaded these visits, he now enjoys them so much he goes to the gym almost every day.
To read more about the finalists and see their before and after photos, visit the Isagenix blog. To learn more about Isagenix, visit the Newsroom, like the company on Facebook, and follow it on Twitter and Instagram.
*Weight loss, muscle gain, lifestyle, and other results depicted here reflect exceptional individual experiences of Isagenix customers and should not be construed as typical or average. Results vary with individual effort, body composition, eating patterns, time, exercise, and other factors, such as genetic and physiological makeup. A two-phase 2016 study published by researchers at Skidmore College showed an average weight loss of 24 pounds after 12 weeks. The study evaluated the use of Isagenix products in men and women for weight loss followed by weight maintenance. During the weight maintenance phase, the subjects who continued the calorie-controlled program using Isagenix products better maintained their weight loss in comparison to those who transitioned to a traditional diet after 52 weeks.
About the IsaBody Challenge
The IsaBody Challenge is a 16-week contest that rewards participants for their total-body and life transformations. Participants are judged on their before and after photos as well as their personal essays describing their journeys. The contest looks for the most inspirational and motivational stories about how participants have made healthy body and life transformations. The IsaBody Challenge is open to all Isagenix customers and members over the age of 18 in the United States, Canada, Puerto Rico, Hong Kong, Australia, New Zealand, Taiwan, Mexico, Singapore, Malaysia, Colombia, Indonesia, the United Kingdom, Ireland, the Netherlands, Belgium, Spain, and South Korea. For more information, visit the IsaBody Challenge page.
About Isagenix International
Established in 2002, Isagenix provides systems for weight loss, performance, vitality and well-being, personal care and beauty, and financial wellness. With nearly 600,000 customers worldwide and more than 100 life-changing products, packs, and systems globally, the company is committed to producing Solutions to Transform Lives™. Isagenix shares its products and solutions through a network of independent distributors in 18 markets: the United States, Canada, Puerto Rico, Hong Kong, Australia, New Zealand, Taiwan, Mexico, Singapore, Malaysia, Colombia, Indonesia, the United Kingdom, Ireland, the Netherlands, Belgium, Spain, and South Korea. Isagenix is a privately owned company with headquarters in Gilbert, Arizona. For more information, visit Isagenix.com.
The Fourth of July is a day for BBQ’s, pool parties, good food, time with family and friends, and enjoying the outdoors. To make this holiday perfect, we have compiled a list of products to make this Independence Day one for the books. On this list are unique snacks and drinks that you would never think of to elevate this years party or get-together. Please let me know if you are interested in more information or sampling any of the following. - Katie
To kick off your day and keep you going strong the whole time, you’ll be obsessed with the coffee from Fire Dept. Coffee! Veteran and Firefighter owned and operated, Fire Dept. Coffee is the fresh, andinnovative coffee company with heart and service backing their brand Breaking the classic coffee mold, the true magic happens with FDC’s more unique flavors; bourbon, whiskey, rum and tequila infused coffee! There four spirit-infused blendspack in all the flavor and energy needed to keep your energy up all day; unique blends with a punch! Each blend is unique and freshly made with lots of flavor -- it’s sure to be your new favorite go-to beverage this holiday! Each batch is roasted to order, ensuring every cup is as fresh and flavorful as possible for when it's needed most. FDC also offers a line of mugs and apparel as well. With honor and reverence in mind, FDC offers 15% off every order for all military and first responders. The team also donates 10% of proceeds from every order towards supporting ill or injured firefighters and first responders. Weather kickstarting your day with a bold blend or unwinding at the end with a delicious cup, Fire Dept. Coffee has the perfect roast for this Fourth. Enjoy coffee made by veterans’ whose heart is to continue to serve our communities. Website: https://www.firedeptcoffee.com/
Be the talk of the party with one of the delicious mixes fromGood Dee’s! Opt for a healthier, yet just as tasty version of your favorite craveable foods this summer with homemade mixes you’ll be obsessed with. From keto and low-carb to gluten-free and dairy-free, Good Dee’s mixes offers consumers living an alternative dietary lifestyle a bold new approach to baked goods that doesn’t involve deprivation. There is finally a delicious and guilt-free way to indulge on your favorite sweet treats with one of the many Good Dee’s mixes. Good Dee’s offers mixes for brownies, cookies, cakes, pancakes, muffins, and cornbread that are diabetic friendly, low-carb, gluten-free, wheat-free, and easy to bake. Dairy-free and nut-free options are also available. The holiday, enjoy sandwichesCorn-Free Cornbread Sandwich BunsorCornbread Dogs! These mixes are the perfect healthy homemade treat! Website: www.gooddees.com
Bubba’s Fine Foods is rewriting the script on boring health food. This brand of delicious gluten-free, grain-free, paleo snacks is giving the people what they want: real food snacks that satisfy real-world cravings. Bubba’s Fine Foods is dedicated to creating healthy and delicious foods that nourishes the body while still tasting amazing! Bubba’s Fine Foods means that health food doesn’t have to be flavorless anymore. Bubba’s is standing apart from other paleo snacks by honing in on what the people want most: an addictive crunch, simple real-food ingredients, no refined sweeteners and healthy snack food that doesn’t taste like it’s healthy. The team has created Snack Mixes, crunchy ‘Nana Chips, and addictive UnGranolas. Their best selling 'Nana Chips Variety Pack is the perfect snack for the kids or health conscious friends. To feed the whole party, try the The Full Family Variety Pack with all three of the Bubba’s hits, making the perfect snack for everyone! All of Bubba’s Fine Foods’ snacks are proudly made in America and are paleo, grain-free, gluten-free, soy-free, dairy-free, non-GMO, and free of refined sugars and artificial flavorings. Website: www.bubbasfoods.com
Emerging Pain Relief Solution from Nutmeg Oil Blend Endorsed by Physical Therapists
Grenada Nut Company’s 100 percent natural nutmeg pain relief oil soothes pain and inflammation in joints, muscles, and more.
MegRelief from Grenada Nut Company is a high-quality nutmeg blend essential oil for muscle pain and stiffness. The oil is certified organic and ISO registered and uses 100 percent natural, raw ingredients.
Arthur and Danette Toole, the founders of Grenada Nut Company, say, “At Grenada Nut Company, we believe no one should be forced to live in pain, nor be forced to take additional medicine. We created MegRelief to be a natural answer to joint and muscle pain. We literally searched all over the globe to find the perfect oils to blend together to provide relief for people like our family members, who suffer from joint and lower back pain.”
Grenada Nut Company was born after Danette took Arthur to visit her father’s home country of Grenada and found nutmeg oil, an oil used for chronic pain. The company’s philosophy is that no one should suffer needlessly when there are natural remedies available.
Grenada Nut Company has partnered with gyms to give customers a better workout experience. Physical therapists, massage therapists, and personal trainers also use the oil on their patients during their rehab sessions.
The founders are so confident in MegRelief, they offer a satisfaction guaranteed policy for all Grenada Nut Company purchases. If the customer is not completely satisfied with the product, they can return it for a full refund. In their first 85 days, Grenada Nut Company had over 290 orders and no joint or muscle pain-related returns.
Grenada Nut Company
Grenada Nut Co. was birthed from pain…literally. While in her family’s home country of Grenada, Danette’s husband had been battling knee pain for 6 months. After several doctor’s visits, scans, physical therapy visits, pain medications, and more scans, the pain still wouldn’t subside.
While there, her parents provided a natural remedy that worked immediately. Then the thought hit them-Why aren’t more people aware of the beautiful and amazing things that Grenada has to offer?
From that thought, Grenada Nut Company was born. Grenada Nut Company seeks to share the wonders of Grenada with the world. From spices and cocoa to fruit and nuts, Grenada is one of the best kept secrets in the Caribbean.
Our philosophy is that no one should suffer needlessly when there are natural remedies available.
WEATHERSFIELD, VERMONT – June 12, 2019 -- Cannatrol today announced the launch of its patent-pending Cannatrol Dry/Cure System, the first-ever to bring technology, science, and complete control to the cannabis finishing process.
Drying and curing ready-to-market legal cannabis harvests today is plagued by over-drying, inconsistent quality, waste, mold, sub-optimal profitability, and overall poor consumer experience. Over-drying results in significant declines in production revenue, while controlled, proper drying can boost margins by as much as 5 percent.
The Cannatrol™ Dry/Cure system provides a controlled, repeatable, chemical- and heat-free drying and curing solution resulting in superior terpene retention, consistent-quality, visually appealing cannabis products for all regulated medical and recreational applications. The Cannatrol system helps producers deliver a premium product, highly differentiated from competitors.
“Cannatrol’s patent-pending technology, takes the guesswork out of cannabis drying and curing to the benefit of growers, processors and end-users,” said David Sandelman, Chief Engineer at Cannatrol and a serial tech innovator. “Cannatrol eliminates heat, over-drying, the challenges of moist coastal air versus dry mountain environments, poor quality, and low profitability from the cannabis finishing process and replaces it with cool air, proven science, and easy to use technology.”
Proven Vaportrol™ Technology
The technology inside Cannatrol was originally developed to solve a drying and aging problem at one of the top cheese makers in the US. Today, the patent-pending technology is being used in hundreds of cheese and cured-meat aging rooms across the country and is the proven standard for high-quality in the food industry. Vaportrol maintains proper vapor pressure throughout the drying and curing process for the food industry and now, through Cannatrol, for the cannabis sector.
How Cannatrol Works
Growing a quality product is a significant financial commitment. Genetics, nutrients, power, and labor all get calculated into the cost of the grow cycle. With that much investment in the grow process, it is critical to assure the product is dried and cured in a clean, correct environment. Anything less can result in a total loss of harvest.
The Cannatrol process starts with gentle, controlled water removal. A typical dry cycle might last from 3-6 days, depending on the cultivar and desired preferences. Users first program the temperature and dew point conditions and the length of time. Second, using the 'ramp' function (with up to 5 settings), Cannatrol gently controls the rate of water loss.
Third, glide into the cure mode. Select temperature and dew point and let the system hold the harvest in a perfectly controlled environment. No maintenance is required. When the cure is complete, finished product can be stored in a sealed container or held in the Cannatrol system until it is packaged and distributed.
The Cannatrol Dry/Cure System
The Cannatrol Dry/Cure system is available for large-scale and commercial growers, as well as a smaller Cool Cure system for small, home growers. The Cool Cure system will dry up to 1 kilo of wet flowers and deliver the same consistent results as the commercial system.
Cannatrol commercial boxes dry/cure from 80 kilos and up and are fitted with an integrated scale to monitor real-time water weight loss, and up to five different settings per dry/cure cycle. Other features of the commercial system to give reliable, repeatable results:
Multi sensor technology
Easy to navigate 7" color touch screen
Remote operating capability via iPhone/Android
Control heat and moisture without supplementary dehumidification
Food grade construction materials
Manual overrides
Installation and tech support/training
Advisory Panel on the Implementation of National Pharmacare Highlights Importance of Biosimilar Medicines
TORONTO, June 12, 2019 /CNW/ - The Advisory Council on the Implementation of National Pharmacare's Final Report highlights the importance of biosimilar medicines in the sustainable implementation of a national pharmacare program.1
The Report states that "Biosimilars are biologic drugs proven to have the same clinical effect as more expensive brand name biologic drugs already authorized for sale. Canada's use of biosimilars has been very low relative to other countries due to a combination of factors, including limited awareness of the clinical and scientific evidence supporting the use of biosimilars and aggressive marketing techniques used by brand name biologic companies to retain their market share."
The Council recommends formulary management policies that "support the use of biosimilars and encourage patients and prescribers to choose the most cost-effective therapies to ensure the sustainability of national pharmacare. Prescribers and patients should be better supported with information reinforcing the safety, efficacy and benefits of biosimilars." While the report makes reference to the "substitution" of biosimilars, the term is not defined in the report.
"Switching or transitioning patients from original biologic treatments to their corresponding biosimilar medicines is the responsible choice for those who manage drug budgets," said Jim Keon, President of Biosimilars Canada. "Such policies are also consistent with Health Canada's recommendation that decisions should be made by the treating physician in consultation with the patient and taking into account available clinical evidence and any policies of the relevant jurisdiction."
"Biosimilars Canada also supports the recommendation that the new Canadian drug agency should work to increase prescriber and public awareness about the equivalency of generics to brand name drugs and the rationale for greater use of generics and biosimilars to keep pharmacare affordable," Keon added.
Canadian payers recognize that enhanced policies are needed to fully realize the value of biosimilar medicines. Biosimilar transitioning or "switching" initiatives have already been implemented in Canada.
In December 2018 private insurance company Green Shield Canada concluded a successful biologic transitioning pilot project.2
In May 2019 the Government of British Columbia announced a new biosimilar transitioning or "switching" initiative where about 20,400 B.C. PharmaCare patients will work with their health-care team to transition from the biologic to the biosimilar drug within six months. The transitioning of a further 2,700 patients should commence this summer. The projected savings allowed for the province to immediately expand coverage to include two additional drugs, and expand access for existing treatments.3
About Biosimilar Medicines A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale.4 Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them.5 Health Canada's rigorous standards for authorization mean that patients and health care providers can have the same confidence in the quality, safety and efficacy of a biosimilar as any other biologic drug.6
About Biosimilars Canada Biosimilars Canada is a national association representing the biosimilar medicines industry in Canada. Its member companies are at the forefront of the global development and marketing of biosimilar medicines. Biosimilar medicines are approved by Health Canada as being as safe and efficacious as their reference biologic drugs, and are developed to the same quality standards. Biosimilar medicines present a significant opportunity to embrace cutting-edge therapies while addressing the cost-effectiveness demands on healthcare systems in Canada. Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association. Visit us at www.biosimilarscanada.ca.
1
Recommendations #31 and #32 pertain to biosimilar medicines.
CGPA Statement on the final report from the Advisory Council on the Implementation of National Pharmacare
TORONTO, June 12, 2019 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the Final Report of the Advisory Council on the Implementation of National Pharmacare:
"The Canadian Generic Pharmaceutical Association and its member companies welcome the recommendations in today's final report from the Advisory Council on the Implementation of National Pharmacare for increasing the use of cost-saving but equally effective generic prescription medicines.
Making prescription drugs more affordable and accessible is the key value proposition of Canada's generic pharmaceutical industry.
In particular, CGPA is pleased with recommendations for mandatory generic substitution policies to encourage patients and prescribers to choose the most cost-effective therapies, and increase patient and prescriber awareness about the equivalency of generic and brand-name prescription medicines.
CGPA estimates that for every one percent increase in the use of generic medicines, Canadians save an additional $586-million. In the United States, for example, generics are dispensed to fill 90 percent of all prescriptions. If the use of generic medicines in Canada was equal to U.S. levels, Canadians would have saved an additional $11-billion in 2018.
Strategies such as charging lower copayments for generic equivalents and addressing the negative impact of brand-name coupon cards are also important initiatives, and CGPA is pleased that the council has stated its support for these measures.
Generic prescription medicines are providing tremendous value and savings for Canadians, largely due to CGPA's initiative with the pan-Canadian Pharmaceutical Alliance (pCPA).
Data released on May 29, 2019 by the federal government's Patented Medicine Prices Review Board (PMPRB) shows that in 2018 Canadian prices for generic prescription medicines dropped to five percent below average or mean prices in comparator countries.
The PMPRB's data also shows that, since 2007, the average price of generic prescription medicines in Canada has fallen by nearly 60 percent, with prices of some of the top-selling generics dropping by an average of 80 percent. While prices of generic medicines have fallen in markets around the world, Canada has experienced the steepest decline of all OECD countries."
About the Canadian Generic Pharmaceutical Association The Canadian Generic Pharmaceutical Association (CGPA) represents Canada's generic pharmaceutical industry. The industry plays an important role in controlling health-care costs in Canada. Generic drugs are dispensed to fill 73 percent of all prescriptions but account for account for less than 20 percent of the $29-billion Canadians spend annually on prescription medicines.
SOURCE Canadian Generic Pharmaceutical Association
Waterloo Region now home to Canada's first industry-led medical technology hub dedicated to helping Canadian start-ups scale globally
KITCHENER, ON, June 13, 2019 /CNW/ - Intellijoint Surgical, a Waterloo Region-based medical device company manufacturing and commercializing smart navigation for total joint replacements, leads the creation of Canada's first industry-led hub dedicated to supporting southern Ontario medtech start-ups achieve global scale while keeping their headquarters in Waterloo Region. Opening this month, MIX - Medical Innovation Xchange - will occupy 30,000 square feet of the west side of the building at 809 Wellington Street North, Kitchener. Intellijoint Surgical is the anchor tenant and will be joined by Penta Medical, Vena Medical, and Bloom Care Solutions; together, they currently employ nearly 100 people. Integrated, community workspace for local health care professionals and smaller medtech companies will also be created. At full capacity, this hub will house 200 people of the local medtech industry.
The number of new Canadian medtech companies starting up in Waterloo Region has grown dramatically in the last 10 years thanks to significant public investment in early-stage research, as well as, the entrepreneurial spirit embraced by so many in the Region. As these companies grow past the start-up phase, they face significant challenges in scaling up successfully within Canada. These challenges are well documented and are headlined by a lack of access to talent, customers and capital. This leads to many start-ups leaving Canada to seek access to the resources they so desperately need.
"Our goal is to create a thriving local medtech ecosystem that supports local companies in achieving scale without having to relocate to Boston, Houston, or any other city outside of the Region," explained Armen Bakirtzian, Intellijoint Surgical CEO & Co-founder. "Launching MIX is the first step to creating an ecosystem that enables the Region to retain and develop talent, create local customers, and attract capital. If we don't fill this gap, we risk the loss of our local medtech companies to the established ecosystems in the US. It's time we create our own ecosystem, retain and develop our highly skilled start-ups, and commercialize Canadian medtech innovations in Canada!"
MIX will connect and unite the medtech community within Waterloo Region, creating a natural collision space for members to share know-how, leverage experience, and ultimately, achieve scale. Members will have direct access to intelligent mentorship and local health care professionals and administrators all housed in this state-of-the-art facility. Access to such resources will help to combat the exodus of Canadian innovation, intellectual property (IP), biomedical engineering talent, and economic value created by maturing medtech companies. The hub will complement the current start-up programming landscape of Waterloo Region and is intended to bridge the gap as start-ups scale.
"The evolution of the local health and medical technology ecosystem is demonstrating the strength of collaboration between the innovation community and clinicians," commented Elliot Fung, Executive Lead, Innovation and Strategic Partnerships, Waterloo Wellington Local Health Integration Network.
"These collaborations have produced new, exciting disruptive health technologies that are improving patient outcomes, wellness and making it easier for clinicians to do what they do best. Co-locating so many innovative scale-ups will allow for health innovators to learn from each other, share successes and mentor each other so that they can maximize opportunities for improvements to patient care. We are very excited to support this next step in establishing Waterloo Region and the province of Ontario as a world class centre for health innovation."
"As medtech companies in the Region mature and phase out of start-up incubators, they are left without the resources they need to continue to develop their product and enter commercialization," said Alexa Roeper, CEO & Founder, Penta Medical. "The collaborative hub of MIX fills this gap through access to affordable lab space, industry-specific knowledge sharing, and one-to-one mentorship centred around the unique challenges that medtech companies face when scaling. MIX has created the option for many local medtech entrepreneurs to remain in the Region and scale successfully."
A grand opening of MIX will be held in the early fall inviting government officials, members of the medtech community and media to tour the facility. To see photos and learn more about Canada's first industry-led hub for medtech scale-ups, visit: www.medicalinnovationxchange.com
Intellijoint Surgical® develops and commercializes surgical navigation solutions. It is committed to improving patients' lives by providing every surgeon with effective, easy-to-use technology. Intellijoint's flagship product, Intellijoint HIP®, provides surgeons with real-time, intraoperative measurements to ensure accurate positioning of orthopaedic implants during total hip replacements.
Bloom was created as an easy to use and innovative reinvention of home health care, ensuring access to quality Health Care Professionals (Care Pro's), improving accountability & efficiencies, facilitating automated scheduling – while enabling technologies to ensure real time communication with both family and care team.
Bloom connects people with Health Care Professionals by combining technology with the highest quality, fully vetted Care Pro's to help facilitate easy scheduling, higher wages, and better service outcomes. All ongoing care is easily managed through the platform – enabling flexibility, real time communication, and responsive service delivery. Bloom is for those seeking the highest quality home care that is fast, safe, secure, and affordable.
Penta Medical has developed PentaVO, a small device which allows patients to treat themselves at home for conditions including arthritis, postoperative recovery, and muscle and tendon tears. It collects biometrics to allow the user to be remotely monitored by their care provider for signs of complications, to improve outcomes through better patient adherence.
Vena Medical is creating a suite of tools to change the way physicians perform minimally invasive neurosurgery. Its flagship product is the world's smallest camera that gives physicians a live imaging-feed from inside veins and arteries within the brain. We've proven the usefulness of this new product in stroke treatment (a $1B market opportunity in the US alone) through a pre-clinical trial performed at the Baylor College of Medicine. Vena Medical has built an advisory team of leading physicians in minimally invasive treatment like Dr. Peter Kan, Chief of Neuroendovascular Service at Baylor St. Luke's Medical Center, and veterans of the medical technologies industry like Maria Aboytes, founder of Medina Medical.
SOURCE Intellijoint Surgical Inc.
Nanalysis secures key strategic investor, Factors Group
CALGARY, June 13, 2019 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI), is pleased to announce it has closed a non-brokered private placement with the Chairman of Factors Group.
The Chairman of Factors Group stated "We are very pleased we are investing in Nanalysis Scientific. Factors Group is committed to producing the highest quality products possible and seeing worldwide improvement of testing in all areas of product quality. The bench-top NMR technology that Nanalysis produces will provide our company with an invaluable tool to confirm source botanical identity and to monitor key active concentrations as products move through the production system and indeed is distributed to our customers, ensuring highest possible safety, potency, purity, and quality. We will be working with Nanalysis and other partners to develop software and reference standard databases that will assist regulatory authorities make progress with their mandates of ensuring nutraceutical authentication, and we will be promoting Nanalysis' products throughout our global network."
This offering is in addition to the concurrent non-brokered unit private placement for gross proceeds of approximately $5,000,000 that was disclosed in the Company's Filing Statement dated May 24, 2019 and closed on June 4, 2019. Pursuant to this Offering, the Company issued 2,500,000 units ("Units") at $0.60 per Unit for a total gross proceeds of $1,500,000. Each Unit consists of one common share of Nanalysis ("Common Share") and one half of one Common Share purchase warrant ("Warrant"). Each whole Warrant will entitle the holder to acquire one additional Common Share for a period of two years following the date of issuance of the Warrant.
The Company will use the net proceeds of the offering for SG&A associated with the global expansion of the Nanalysis' sales organization and distribution network and for working capital.
All securities issued pursuant to the Offering are subject to a statutory hold period of four months and one day from the date of issuance.
About Factors Group
Factors Group has been a producer of the highest quality Natural Health Products and dietary supplements for over 50 years. Factors Group operates across nine locations in North America: housing offices, manufacturing and production facilities, laboratories, distribution centers, and extensive warehouses. The company also grows on its own pristine farm land. Factors' head office is in Coquitlam, BC with a US office in Monroe, Washington. The company's mission is to enhance the well-being of its customers through research, development, and delivery of effective nutritional supplements and other health-building products. http://factorsgroup.com
About Nanalysis Scientific
Nanalysis (TSXV:NSCI) has been in business for 10 years developing/manufacturing portable Nuclear Magnetic Resonance (NMR) spectrometers for the laboratory instrumentation market. Nanalysis products are used by industry (oil & gas, chemical, pharma, biotech, food science, atomic agencies) and are category leaders in teaching/research. http://www.nanalysis.com/investor-relations
Nanalysis Scientific Corp. seeks safe harbor for any forward-looking statements in this release. Investors should not rely on information in this release to make any investment decisions but rather should consult an independent financial advisor.
SOURCE Nanalysis Scientific Corp.
Rapid Dose Therapeutics Announces Commercialization of QuickStrip™ Oral Thin Strips
Licensee, Chemesis International Inc., begins efforts for distribution of QuickStrip™ across United States & Puerto Rico
BURLINGTON, ON, June 13, 2019 /CNW/ - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, announces that Chemesis International Inc. (CSE:CSI), a Licensee, has begun commercialization of QuickStrip™Oral Thin Strips. Chemesis will deliver CBD infused strips across the United States as well as THC and CBD infused strips in Puerto Rico.
Chemesis' subsidiary, Natural Ventures, operates a facility with the infrastructure required to manufacture, package and distribute QuickStrip™ Oral Thin Strips. Chemesis will distribute QuickStrip™ through Natural Ventures distribution network and existing relationships in Puerto Rico.
As the Company continues to expand its manufacturing, Chemesis will look to add additional infrastructure for its QuickStrip™ Oral Thin Strips in California. In anticipation of federally changing CBD regulations, Chemesis has begun signing distribution agreements in the mainland United States for CBD infused QuickStrip™ products to ensure the Company maintains a first mover advantage by forming distribution channels and partnerships that will gain market share. The RDT proprietary drug delivery technology is infused with CBD, THC and other cannabinoids.
The Rapid Dose Therapeutics proprietary QuickStrip™ delivery system is a true sublingual delivery device for THC, CBD and other cannabinoids. Furthermore, QuickStrip™ is conducting controlled trials to further demonstrate QuickStrip™ effectiveness and consistent onset. Chemesis believes this technology is at the forefront of sublingual delivery systems and will expand its efforts to bring it to market.
"Through our Managed Strip Services Agreement (MSSA), Rapid Dose is focused and committed to providing consumers in the United States and Puerto Rico cannabis markets a Smoke‐Free Choice™," said Mark Upsdell, CEO of Rapid Dose. "RDT's agreement with Chemesis will enable them to manufacture and sell under both their own private brand and as part of our white label program. Our brand partnership with Chemesis further strengthens and positions QuickStrip™ for rapid growth as an international brand and delivery device to cannabis consumers while delivering health and improving outcomes. With the QuickStrip™ discreet and measured dosing, Chemesis is well positioned to bring a unique and exciting product offering to Puerto Rico and U.S. markets and we are thrilled to be an integral part of their growth."
About Rapid Dose Therapeutics
Rapid Dose Therapeutics Corp. is a publicly-traded Canadian life sciences company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry, including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT provides a turn-key Managed Strip Service Program which enables RDT's QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT's service based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets — generating value for consumers and shareholders. Rapid Dose Therapeutics is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs — including humans, animals and plants.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward- looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of products using the QuickStrip™ product delivery method, express, as at the date of this news release, the plans, estimates, forecasts, projections, expectations or beliefs of RDT as to future events or results and are believed to be reasonable based on information currently available to them. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Rapid Dose Therapeutics Corp.
Mayor Bevilacqua Makes A Historic Announcement at the 2019 Mayor's Gala
Cortellucci family makes historic $40-million donation to new Mackenzie Vaughan Hospital
VAUGHAN, ON, June 13, 2019 /CNW/ - It gives me immense pleasure to officially announce that the Cortellucci family has donated a historic $40 million toward building the new Mackenzie Vaughan Hospital, Mayor Maurizio Bevilacqua said in a keynote address to an audience of nearly 1,000 people during the 2019 Mayor's Gala.
Mayor Bevilacqua chairs the $250-million Mackenzie Health Foundation's Exceptional Care Belongs Here Campaign. More than $160 million have been raised toward constructing Vaughan's first hospital. "The Cortellucci family's donation marks the largest single contribution in Mackenzie Health's history," Mayor Bevilacqua said.
The Cortellucci family has an admirable, selfless and extensive history of giving back to ensure Vaughan has a bright and promising future. In July 2018, Mayor Bevilacqua hosted a special ceremony at Vaughan City Hall to announce the Cortellucci family had stepped forward with a $3-million donation that will go toward building the Hospice Vaughan – Mario & Nick Cortellucci Hospice Palliative Care Centre of Excellence. Mayor Bevilacqua also chairs Hospice Vaughan's A Better Ending Capital Campaign.
In January 2019, Mayor Bevilacqua was joined by the Cortellucci family to announce the expansion of Niagara University's new campus to the Vaughan Metropolitan Centre, the city's emerging downtown core. It is located walking distance from the VMC TTC subway station and further connected by vivaNext bus rapid transit service. Niagara University is the first university in Vaughan and York Region.
Cranes tower over the 1.2-million square foot Mackenzie Vaughan Hospital site, which can house up to 550 beds. The new hospital is a $1.6-billion initiative. It will employ over 1,800 full-time hospital staff and be the first in Canada to feature fully integrated smart technology systems and medical devices that can speak directly to one another to maximize patient care. Last fall, Mayor Bevilacqua, Members of Council and the community marked the hospital topping-off ceremony to celebrate reaching the highest point of construction and moving closer to opening the hospital in late 2020.
The 2019 Mayor's Gala theme is #WeAreVaughan. It represents pride of citizenship and the knowledge that all people have an important and enduring role in creating a city that is admired across the country and around the world. Since 2011, the efforts and events of Mayor Bevilacqua's Spirit of Generosity commitment have raised more than $70 million. Proceeds have gone to help over 200 not-for-profit and community organizations that play a vital role in shaping the City of Vaughan.
QUOTES
"The 2019 Mayor's Gala is a momentous occasion. This year's gala will be remembered, cherished and celebrated as another important milestone embodying the work we have undertaken to ensure people have access to modern, quality and world-class front-line healthcare. Vaughan is blessed to be the destination of choice for so many families who have chosen to make Canada their home. Like many men and women who immigrated to Canada, the Cortellucci family have spent their lives giving back, helping all people, especially our most vulnerable citizens. Their exceptional generosity and support for the Mackenzie Vaughan Hospital is an example of what we can achieve when we work together. The Cortellucci family are philanthropic leaders and Vaughan's first-ever hospital will stand as a testament to their inspiring legacy of unwavering public service." - Mayor Maurizio Bevilacqua
"Our family's journey is one that embodies the immigrant experience. It is to work hard, do your best, contribute and share your blessings. We are especially grateful to the Vaughan community that we have called home for the last 25 years. And, we are humbled to contribute to the Vaughan Hospital, Canada's first 'smart' hospital. By planting these seeds, we are helping a community and the members within it to flourish." - Mario Cortellucci on behalf of the Cortellucci family
"Today's announcement is a major step forward in building the 'smart' hospital our community deserves. We're grateful to the Cortellucci family for their leadership, generosity and commitment to improving the health and wellness of all patients and their families in York Region and the promise of care close to home it inspires." - Altaf Stationwala, President and CEO, Mackenzie Health
QUICK FACTS
Proceeds from the Mayor's Gala and Mayor Maurizio Bevilacqua Annual Charity Golf Classic have been used for many important purposes. These include iPads for youth with autism, expansion of hospice programs, camp programs for children, toys for kids at Christmas, support for victims of abuse and a new home for adults with special needs.
The 2019 City of Vaughan Mayor's Gala #WeAreVaughan is presented by HBNG (Holborn Group) and RGF (Real Estate Fund L.P.)
ABOUT VAUGHAN: The City of Vaughan is one of Canada's fastest growing cities with a population of more than 335,000. Incorporated in 1991, Vaughan includes the communities of Concord, Kleinburg, Maple, Thornhill and Woodbridge. This culturally diverse municipality is located in the heart of York Region and the Greater Toronto Area.
SOURCE City of Vaughan
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
